AstraZeneca
PulseAugur coverage of AstraZeneca — every cluster mentioning AstraZeneca across labs, papers, and developer communities, ranked by signal.
- parent of Amylin Pharmaceuticals 100%
- subsidiary of BlackRock 100%
- subsidiary of Wellington Management Company 100%
- subsidiary of Capital Group Companies 100%
- parent of Moderna 100%
- partners with Abu Dhabi 90%
- partners with CSPC Pharmaceutical Group 80%
- instance of Astra 70%
- invested in CSPC Pharmaceutical Group 60%
- headquartered in Abu Dhabi 50%
- 2026-11-02 research_milestone AstraZeneca and Qure.ai reached a milestone of 5 million AI-enabled chest X-rays. source
- 2026-10-31 partnership AstraZeneca and Oracle Health and Life Sciences announced a global AI collaboration in healthcare. source
- 2026-10-20 partnership AstraZeneca and Oracle are partnering to use AI and patient data to speed up drug trial recruitment. source
- 2026-10-20 partnership AstraZeneca partnered with Oracle to launch AI-driven real-world data trials in Abu Dhabi. source
- 2026-08-08 partnership AstraZeneca formed a joint venture with CSPC Pharmaceutical Group to focus on manufacturing and supply for the global market. source
- 2026-08-02 partnership AstraZeneca has reportedly explored an acquisition of Bristol Myers Squibb. source
- 2026-08-02 partnership AstraZeneca and Bristol Myers Squibb have reportedly held early-stage merger discussions. source
11 day(s) with sentiment data
-
Global stocks plunge amid AI slowdown fears after Democratic midterm wins · 8 sources tracked
Global stock markets experienced a significant downturn, with major indices in the US, Europe, and Asia plunging due to fears of an AI industry slowdown. This sell-off was triggered by the Democratic Party's success in …
-
AstraZeneca and Qure.ai hit 5M AI-enabled chest X-rays milestone
AstraZeneca and Qure.ai have successfully completed 5 million artificial intelligence-enabled chest X-rays across more than 20 countries. This initiative aims to facilitate the early detection of lung cancer risk, parti…
-
AstraZeneca and Oracle partner on AI for healthcare in Abu Dhabi
AstraZeneca and Oracle Health and Life Sciences have initiated a global collaboration centered on artificial intelligence within healthcare. Their initial focus is on addressing uncontrolled hypertension in Abu Dhabi th…
-
Oracle and AstraZeneca partner on AI for clinical trial recruitment
Oracle and AstraZeneca have partnered to investigate how artificial intelligence, cloud computing, and real-world health data can improve the identification of suitable candidates for clinical trials. This collaboration…
-
Quantum Computing's Rise Prompts Calls for Chief Quantum Officer Role
The emergence of quantum computing is prompting discussions about creating a dedicated C-suite role, similar to the rise of Chief AI Officers. While currently rare, the complexity and potential impact of quantum technol…
-
Oracle, AstraZeneca, M42 launch AI-driven clinical trials in Abu Dhabi
Oracle, AstraZeneca, and M42 have launched an AI-powered initiative in Abu Dhabi aimed at speeding up clinical trials. The program will initially focus on identifying patients with uncontrolled hypertension to improve c…
-
Oracle and AstraZeneca explore AI for clinical trial acceleration
Oracle and AstraZeneca are collaborating to investigate the use of artificial intelligence and real-world health data. The goal is to improve the identification of suitable patients for clinical trials and expedite medi…
-
AstraZeneca to sell China-developed lung cancer drug sunvozertinib in US
AstraZeneca will begin selling sunvozertinib, a lung cancer drug developed by China's Dizal Pharmaceutical, in the United States. The decision follows criticism over delays in making the drug available, which prompted s…
-
AstraZeneca and Oracle partner on AI for faster drug trial recruitment
AstraZeneca and Oracle have formed a partnership to leverage artificial intelligence and patient health data. This collaboration aims to expedite the process of identifying suitable participants for clinical drug trials.
-
AstraZeneca and Oracle launch AI-driven clinical trials in Abu Dhabi
AstraZeneca is collaborating with Oracle to implement AI-driven real-world data trials in Abu Dhabi. This partnership aims to accelerate patient recruitment and enhance safety monitoring for clinical trials across vario…
-
Meta's new terms could allow AI training on business websites
Meta's updated business terms, effective October 30, could allow the company to scrape content from business websites using its platforms like Instagram for AI training. Legal experts suggest this could extend to full a…
-
Nordic countries emerge as AI infrastructure and innovation hub powered by NVIDIA
The Nordic region is solidifying its position as a leading European technology hub, driven by abundant renewable energy and a strong research tradition. Several Nordic countries are rapidly expanding their AI infrastruc…
-
Biotech IPOs surge with over two dozen companies public this year
The biotech sector has seen a significant increase in companies going public this year, with over two dozen already having completed their IPOs. This trend is expected to continue, with more companies preparing to enter…
-
Sweden's $5B VC forecast signals enduring innovation model · 1 source tracked
Sweden is projected to raise $5 billion in venture capital by 2026, significantly outpacing growth in Germany and France. This success is attributed to a 150-year-old model that fosters innovation through inventor-frien…
-
Europe aims to leverage industrial data for AI advantage amid U.S. investment gap
Europe is significantly trailing the U.S. and China in AI investment and company valuations, with U.S. private investment in AI reaching $285.9 billion in 2025 compared to Europe's $20.9 billion. Peter Koerte, CEO of Si…
-
AI victim testimony allowed in Arizona sentencing hearing
In a recent Arizona case, a court permitted the family of a murder victim to present an AI-generated video of the victim speaking at the sentencing hearing. The AI depiction included the victim explaining its nature and…
-
AstraZeneca calls for new funding model to boost Hong Kong biotech investment
AstraZeneca, a global pharmaceutical company, has stated that Hong Kong requires a new financial model to attract further investment from drug makers. Despite conducting over 60 clinical trials worth US$25.5 million in …
-
Global interest in Chinese biotech surges with major pharma deals
Global interest in Chinese biotech is rising, evidenced by significant deals involving major pharmaceutical companies. AstraZeneca is investing $2 billion in Summit Therapeutics, which is advancing Akeso's immunotherapy…
-
Hong Kong tech hub selects 100 startups for long-term mentorship
Hong Kong's flagship tech hub, the Hong Kong-Shenzhen Innovation and Technology Park (HSITP), has selected approximately 100 start-ups to join its program. These selected companies will benefit from mentorship lasting f…
-
Arm Holdings CEO: AI will cure cancer in our lifetime · 2 sources tracked
The chief executive of Arm Holdings, René Haas, has expressed optimism that artificial intelligence will lead to a cure for cancer within our lifetimes. He believes that while current AI models struggle with the complex…